Meet Castle Creek Pharma.
HQ: Parsippany, NJ
Leadership: Jeffrey Aronin, Greg Wujek
Opportunity: To help patients with skin conditions who have a high unmet need, with an initial focus on epidermolysis bullosa ("EB"), a rare, potentially severely debilitating dermatologic condition that usually begins in infancy and causes painful blisters on the skin and internal organs as a result of friction and trauma.
Vision: Become one of the industry’s most prolific developers of innovative and high potential late stage therapies for rare genetic dermatology conditions.